Gracias Antonio J. — SEC insider filings

SEC reporting owner CIK 1495158. 17 insider filings on record with FilingPulse; latest filed 2026-09-30.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-08-20 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tesla, Inc. (TSLA)Director43 legs · 105 sh · $41,48818 legs · 305,747 sh · $193,405,3079
Harmony Biosciences Holdings, Inc. (HRMY)Director, 10% owner10—2 legs · 4,600,000 sh · $139,391,50015
BITGO HOLDINGS, INC. (BTGO)10% owner1——16
SPACE EXPLORATION TECHNOLOGIES CORP (SPCX)Director2——2

Insider filings — Gracias Antonio J.

FiledFormIssuerReported transactionsSource
2026-09-304/ASPACE EXPLORATION TECHNOLOGIES CORP (SPCX)Other (J): 42,790,223EDGAR
2026-09-154SPACE EXPLORATION TECHNOLOGIES CORP (SPCX)Other (J): 42,790,223EDGAR
2026-01-274BITGO HOLDINGS, INC. (BTGO)
jointly with Valor Digital Investments, LLC, Valor Management L.P.
Conversion (C): 9,201,725 · Conversion (C): 330,277 · Conversion (C): 1,175,180 · Conversion (C): 26,140 · Conversion (C): 649,193 · Conversion (C): 229,502 (derivative) @ $0 · +10 moreEDGAR
2025-09-024Harmony Biosciences Holdings, Inc. (HRMY)
jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A.
Other (J): 6,618,033EDGAR
2025-05-164Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 14,522 (derivative) @ $0EDGAR
2024-11-054Harmony Biosciences Holdings, Inc. (HRMY)
jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A.
Sale (S): 4,000,000 @ $30.30 · Sale (S): 600,000 @ $30.30EDGAR
2024-05-314Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 8,870 (derivative) @ $0EDGAR
2023-05-264Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 7,314 (derivative) @ $0EDGAR
2022-05-244Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 6,639 (derivative) @ $0EDGAR
2021-06-144Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 10,144 (derivative) @ $0EDGAR
2021-04-054Tesla, Inc. (TSLA)Purchase (P): 70 @ $377.42 · Purchase (P): 25 @ $375.71 · Purchase (P): 10 @ $567.60EDGAR
2021-02-104Tesla, Inc. (TSLA)Option exercise (M): 97,000 @ $52.38 · Option exercise (M): 53,747 @ $68.56 · Sale (S): 1,930 @ $842.60 · Sale (S): 13,256 @ $843.51 · Sale (S): 22,036 @ $844.37 · Sale (S): 22,122 @ $845.36 · +7 moreEDGAR
2020-12-184Tesla, Inc. (TSLA)Gift (G): 40,000 @ $0EDGAR
2020-10-284Tesla, Inc. (TSLA)Option exercise (M): 127,500 @ $50.14 · Option exercise (M): 27,500 @ $52.38 · Sale (S): 8,092 @ $421.58 · Sale (S): 1,005 @ $421.94 · Sale (S): 25,863 @ $422.62 · Sale (S): 37,296 @ $423.46 · +7 moreEDGAR
2020-09-044/AHarmony Biosciences Holdings, Inc. (HRMY)
jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A.
Conversion (C): 10,139,645 · Conversion (C): 233,052 · Conversion (C): 75,000,000 (derivative) @ $0 · Conversion (C): 1,786,985 (derivative) @ $0EDGAR
2020-08-254Harmony Biosciences Holdings, Inc. (HRMY)
jointly with Valor IV Pharma Holdings, LLC, Valor Management L.P., Valor Equity Capital IV LLC, Valor Equity Associates IV L.P., VALOR EQUITY PARTNERS IV L.P., VALOR EQUITY PARTNERS IV-A L.P., VALOR EQUITY PARTNERS IV-B L.P., Sabater Juan A.
Conversion (C): 12,080,352 · Conversion (C): 240,668 · Conversion (C): 77,950,712 (derivative) @ $0 · Conversion (C): 1,810,126 (derivative) @ $0EDGAR
2020-08-204Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 12,617 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1495158 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs